Delivery Order SPE2DB22D9151-SPE2DB25FM8GV
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a $45,905 delivery order by the Defense Logistics Agency (DLA) on April 24, 2025, for the supply of Botox 200 unit vials. This firm fixed-price delivery order, with an ultimate completion date of May 15, 2025, represents a discrete task order issued under DMS Pharmaceutical Group's substantial Indefinite Delivery Contract (IDC) with the DLA valued at $500 million...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $19.4K by the Defense Logistics Agency (DLA) on August 25, 2025, for the supply of Botox 200 unit vials. The delivery order carries an ultimate completion date of September 16, 2025, and represents a non-set-aside competitive award. This delivery order falls under DMS Pharmaceutical Group's larger single-award Indefinite...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $7,762.20 by the Defense Logistics Agency for the supply of Botox 200 unit vials. This firm fixed-price delivery order, awarded on August 25, 2025, with an ultimate completion date of September 16, 2025, represents a direct pharmaceutical supply requirement for Department of Defense healthcare facilities. The award was executed without a...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order for BOTOX 200 Unit Vials valued at $12,937.00 by the Defense Logistics Agency (DLA) on July 29, 2025, with an ultimate completion date of August 19, 2025. This firm fixed-price delivery order was issued without a set-aside designation and will be performed at the contractor's Park Ridge facility. The award is issued under the company's existing...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a delivery order award from the Defense Logistics Agency (DLA) on August 27, 2025, for the supply of Botox 200 unit vials. This firm fixed-price delivery order, valued at $64.7K with an ultimate completion date of September 18, 2025, carries no set-aside designation. The award represents a task order issued under DMS Pharmaceutical Group's larger Indefinite Delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order by the Defense Logistics Agency (DLA) for 200-unit vials of Botox, with a contract ceiling value of $9,702.75. The award, issued on September 18, 2025, carries an ultimate completion date of October 9, 2025, and utilizes firm fixed-price pricing. This delivery order is issued without a set-aside designation and represents performance work to be...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $10,349.60 by the Defense Logistics Agency (DLA) on September 17, 2025, for the supply of Botox 200 unit vials. The order carries an ultimate completion date of October 8, 2025, and will be performed at the contractor's location in Park Ridge, Illinois. This delivery order was issued without a set-aside designation,...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was awarded a delivery order valued at $2,587.40 by the Defense Logistics Agency (DLA) on September 11, 2025, for the supply of Botox 200-unit vials. This firm fixed-price delivery order, with an ultimate completion date of October 2, 2025, represents a discrete purchase under the company's larger Indefinite Delivery Contract with DLA valued at approximately $500 million...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $3,234.25 for Botox 200-unit vials by the Defense Logistics Agency (DLA). The contract is a firm fixed-price delivery order with an ultimate completion date of October 6, 2025, and carries no set-aside designation. This award represents a discrete order issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,587.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of BOTOX 200 Unit Vials. The contract, executed on August 8, 2025, with an ultimate completion date of August 29, 2025, operates under a firm fixed-price structure with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite...
- SPE2DB22D9151Indefinite Delivery Contract
- SPE2DB22D9151-SPE2DB25FM8GVDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a $2,754.30 firm fixed-price delivery order by the Defense Logistics Agency (DLA) on May 20, 2025, for the supply of Botox 200 unit vials. The delivery order, which carries an ultimate completion date of June 11, 2025, was issued without a set-aside designation. This award is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at $499,999,999 and valid through November 2026, which enables the agency to procure a comprehensive range of pharmaceutical products supporting medical supply needs across Department of Defense healthcare facilities worldwide. As a crucial supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group leverages its status as a woman-owned small business to compete effectively in federal procurement markets while maintaining a robust portfolio of pharmaceutical product deliveries to government healthcare systems. The DLA SPE2DB program vehicle under which this delivery order was issued facilitates the efficient distribution of branded and generic prescription drugs, biologics, and medical consumables to military health facilities. This specific delivery order for Botox represents one component of the company's ongoing commitment to providing specialized pharmaceutical products that support the diverse medical supply requirements of the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 5/20/25 |